Sarantis Worldwide


Visit our group site

Sarantis Group| English

Or choose a location

INVESTOR'S PRESS

IR Releases

14 NOVEMBER 2024

Purchase of own shares

SARANTIS S.A. (“the Company”) announces that, in implementation of the resolution of the Shareholders’ Annual General Meeting dated April 23rd 2024, the Company proceeded on November 13th 2024 with the purchase of 8,700 own shares at the average price of 10.

13 NOVEMBER 2024

Purchase of own shares

SARANTIS S.A. (“the Company”) announces that, in implementation of the resolution of the Shareholders’ Annual General Meeting dated April 23rd 2024, the Company proceeded on November 12th 2024 with the purchase of 5,250 own shares at the average price of 10.

12 NOVEMBER 2024

Participation of Sarantis Greece brands Lanes, clinéa, Bio-Oil and PiC at the 8th PEIFASYN Conference

Sarantis Health & Care division participated for the second consecutive year in the Conference of the Piraeus Pharmaceutical Association, held on Sunday, November 3, 2024, at the iconic Zappeion Megaron.

12 NOVEMBER 2024

Purchase of own shares

SARANTIS S.A. (“the Company”) announces that, in implementation of the resolution of the Shareholders’ Annual General Meeting dated April 23rd 2024, the Company proceeded on November 11th 2024 with the purchase of 7,700 own shares at the average price of 10.

11 NOVEMBER 2024

Purchase of own shares

SARANTIS S.A. (“the Company”) announces that, in implementation of the resolution of the Shareholders’ Annual General Meeting dated April 23rd 2024, the Company proceeded on November 8th 2024 with the purchase of 3,500 own shares at the average price of 10.

8 NOVEMBER 2024

Purchase of own shares

SARANTIS S.A. (“the Company”) announces that, in implementation of the resolution of the Shareholders’ Annual General Meeting dated April 23rd 2024, the Company proceeded on November 7th 2024 with the purchase of 1,980 own shares at the average price of 11.

7 NOVEMBER 2024

Purchase of own shares

SARANTIS S.A. (“the Company”) announces that, in implementation of the resolution of the Shareholders’ Annual General Meeting dated April 23rd 2024, the Company proceeded on November 6th 2024 with the purchase of 4,822 own shares at the average price of 10.

6 NOVEMBER 2024

Purchase of own shares

SARANTIS S.A. (“the Company”) announces that, in implementation of the resolution of the Shareholders’ Annual General Meeting dated April 23rd 2024, the Company proceeded on November 5th 2024 with the purchase of 6,800 own shares at the average price of 10.

Press Releases

Want to learn more about the Group?
Explore our latest news regarding our brands, our activities, our people and our sustainability actions!

More
Change cookies consent Revoke cookies consent